Advanced glycation end-products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes

被引:72
|
作者
Cartledge, JJ
Eardley, I
Morrison, JFB
机构
[1] St Jamess Univ Hosp, Pyrah Dept Urol, Leeds LS9 7TF, W Yorkshire, England
[2] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Physiol, Al Ain, U Arab Emirates
关键词
erectile dysfunction; diabetes mellitus; advanced glycation end-products (AGEs); aminoguanidine;
D O I
10.1046/j.1464-410x.2001.00067.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine if advanced glycation products (AGEs) are responsible for the lower neuronal and endothelial-derived nitric oxide (NO)mediated relaxation of corpus cavernosum in tissue in diabetic rats than in control rats. Materials and methods Diabetes was induced in male Wistar rats by an intraperitoneal injection with streptozotocin (60 mg/kg). One group of diabetic rats was given free access to water and standard diet. A second group was given standard diet and aminoguanidine with their water (50 mg/100 mL) from the initiation of diabetes. Two groups of rats that were not diabetic acted as age-matched controls. After 8 weeks animals were killed by cervical dislocation, corpus cavernosal tissue strips harvested and in an organ bath to measure isometric After 90 min of equilibration at optimal resting tension and contraction with 1 mu mol/L noradrenaline, the response to either acetylcholine or electrical field stimulation (EFS) after adding guanethidine (5 mu mol/L) and atropine (1 mu mol/L) was determined for each group. Results There was no difference between the baseline characteristics of all the experimental groups. After 8 weeks the mean body mass and glycosylated haemoglobin (HbA(1c)) were significantly greater in the diabetic than in control animals. Aminoguanidine had no effect on the recorded body mass or HbA(1c). The in vitro relaxation response to the application of acetylcholine or EFS of tissue strips from age-matched control animals fed a standard diet and those supplemented with aminoguanidine were the same. The administration of aminoguanidine to diabetic animals for 8 weeks reversed the expected impaired relaxation response to acetylcholine; the response to EFS was similar. Conclusion AGEs are more prevalent in erectile tissue from diabetic than in control animals. Aminoguanidine reversed the impairment in neuronal and endothelial NO-mediated penile smooth muscle relaxation seen in diabetes. As aminoguanidine prevents AGE formation, erectile dysfunction in diabetes is probably caused partly by the generation of AGEs.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 50 条
  • [41] Role of advanced glycation end-products in obesity-related ovarian dysfunction
    Merhi, Z.
    Mcgee, E. A.
    Buyuk, E.
    MINERVA ENDOCRINOLOGICA, 2014, 39 (03) : 167 - 174
  • [42] The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
    Fishman, Sarah Louise
    Sonmez, Halis
    Basman, Craig
    Singh, Varinder
    Poretsky, Leonid
    MOLECULAR MEDICINE, 2018, 24
  • [43] Association between Advanced Glycation End-Products, Carotenoids, and Severe Erectile Dysfunction
    Fujita, Naoki
    Ishida, Mizuri
    Iwane, Takuro
    Suganuma, Hiroyuki
    Matsumoto, Mai
    Hatakeyama, Shingo
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Mikami, Tatsuya
    Itoh, Ken
    Ohyama, Chikara
    WORLD JOURNAL OF MENS HEALTH, 2023, 41 (03) : 701 - 711
  • [44] Increased advanced glycation end-products (AGEs) assessed by skin autofluorescence in schizophrenia
    Kouidrat, Youssef
    Amad, Ali
    Desailloud, Rachel
    Diouf, Momar
    Fertout, Eva
    Scoury, Daphne
    Lalau, Jean-Daniel
    Loas, Gwenole
    JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (08) : 1044 - 1048
  • [45] Advanced glycation end-products induce cell cycle arrest and hypertrophy in podocytes
    Ruester, Christiane
    Bondeva, Tzvetanka
    Franke, Sybille
    Foerster, Martin
    Wolf, Gunter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (07) : 2179 - 2191
  • [46] The specific localization of advanced glycation end-products (AGEs) in rat pancreatic islets
    Morioka, Yuta
    Teshigawara, Kiyoshi
    Tomono, Yasuko
    Wang, Dengli
    Izushi, Yasuhisa
    Wake, Hidenori
    Liu, Keyue
    Takahashi, Hideo Kohka
    Mori, Shuji
    Nishibori, Masahiro
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2017, 134 (04) : 218 - 224
  • [47] Advanced glycation end-products: Mechanics of aged collagen from molecule to tissue
    Gautieri, Alfonso
    Passini, Fabian S.
    Silvan, Unai
    Guizar-Sicairos, Manuel
    Carimati, Giulia
    Volpi, Piero
    Moretti, Matteo
    Schoenhuber, Herbert
    Redaelli, Alberto
    Berli, Martin
    Snedeker, Jess G.
    MATRIX BIOLOGY, 2017, 59 : 95 - 108
  • [48] The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review
    Sarah Louise Fishman
    Halis Sonmez
    Craig Basman
    Varinder Singh
    Leonid Poretsky
    Molecular Medicine, 2018, 24
  • [49] Effects of Ginkgo biloba extracts with mirodenafil on the relaxation of corpus cavernosal smooth muscle and the potassium channel activity of corporal smooth muscle cells
    Kim, Jung Jun
    Han, Deok Hyun
    Lim, Soo Hyun
    Kim, Tae Hun
    Chae, Mee Ree
    Chung, Kyung Jin
    Kam, Sung Chul
    Jeon, Ju-Hong
    Park, Jong Kwan
    Lee, Sung Won
    ASIAN JOURNAL OF ANDROLOGY, 2011, 13 (05) : 742 - 746
  • [50] Advanced glycation end products and diabetes and other metabolic indicators
    Jiang, Tian
    Zhang, Yi
    Dai, Fang
    Liu, Chao
    Hu, Honglin
    Zhang, Qiu
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01)